Fulgent Genetics

Fulgent Genetics is a CAP and CLIA certified genetics lab in Los Angeles that's dedicated to high quality and affordable genetic testing.

[Fulgent Genetics @FulgentGenetics]

Today at #ASCO26, our team presented updated Phase 2 data on FID-007 + cetuximab. Thank you to the patients, investigators, and partners who made this possible. A Phase 3 study is planned.

Full release: https://t.co/beB355tQ0S

[Fulgent Genetics @FulgentGenetics]

Fulgent is excited to exhibit at this year’s Festival of Genomics, Biodata & AI in Boston. Find us at booth 19, June3-4 to discuss new testing capabilities or just chat about genomics!

#FestivalOfGenomics #FOG2026 #AIinGenomics #PrecisionMedicine #MultiOmics

[Fulgent Genetics @FulgentGenetics]

We've expanded our cardiovascular panel menu, including 99 newly added genes on our Comprehensive Cardiovascular NGS Panel (now 363 total) and a new Comprehensive Dyslipidemia Panel. Learn more: https://t.co/j1Y2GkLvXu

#FulgentGenetics #Cardiogenetics #GeneticTesting

[Fulgent Genetics @FulgentGenetics]

Interim Phase 2 data on FID-007 in combination with cetuximab show a 60% objective response rate and favorable safety in R/M #HNSCC.

Read the full abstract now on the ASCO 2026 site, and learn more at: https://t.co/qWSeabJAWM

#ASCO26

[Fulgent Genetics @FulgentGenetics]

Headed to #ASCO26? Stop by booth #11094 to meet us.

We support clinical oncology teams with solid tumor NGS (incl. MSI/TMB), heme panels, ctDNA, HRR/HRD, germline, and IHC/FISH — across CLIA/CAP labs in the US, Australia, and China.

#PrecisionOncology #PrecisionMedicine

[Fulgent Genetics @FulgentGenetics]

We Have Everything Under the Sea 🌊 Catch us at #APG2026's Exhibit Fair & Strolling Dinner — Thursday 5/28, 6:00–9:00 PM in San Diego. #FulgentGenetics

[Fulgent Genetics @FulgentGenetics]

May is #EDSAwarenessMonth. Two panel updates from Fulgent: our EDS Panel now includes 39 genes across all 13 EDS types, and our Comprehensive Connective Tissue Disease Panel covers 119 genes, including EDS, Marfan, Loeys-Dietz, Stickler, and TAAD. #GeneticTesting

[Fulgent Genetics @FulgentGenetics]

Our infertility NGS panels just got broader:
✓ Female Infertility Panel: +41 genes (now 143) — incl. all OZEMA genes
✓ Male Infertility Panel: +17 genes (now 163)

Pair with #BeaconCarrierScreening for a fuller picture. One partner, every step.
https://t.co/RtBPgeHPLY

[Fulgent Genetics @FulgentGenetics]

Lab workers are the all-too-often unsung heroes of healthcare. So this #labweek, we'd like to express our gratitude to the Fulgent lab staff who work tirelessly behind the scenes on behalf of patients and the healthcare community. Thank you for all you do.

[Fulgent Genetics @FulgentGenetics]

The latest findings on the efficacy of Fulgent's nano-encapsulated anti-tumor drug FID-007 will be presented at this year's American Society of Clinical Oncology (@ASCO) meeting.

https://t.co/IkwWHOFoyW

[Fulgent Genetics @FulgentGenetics]

We’re at #AACR26! Visit Booth # 4354 to connect with our team about oncology services for clinical care and research, including Olink proteomics, IDVR NGS panels, and TSO500 v2 + HRD tumor profiling. Let’s explore collaboration! #NGS #Oncology #Biomarkers #Proteomics

[Fulgent Genetics @FulgentGenetics]

Meet us at #AACR26 Booth 4354! See why Fulgent is trusted by top pharma for drug discovery, assay validation, and clinical translation.

Explore our multiomic solutions: CE-IVDR NGS panels, TSO500 v2 + HRD, and Olink® proteomics.

Schedule with us at: [email protected]

[Fulgent Genetics @FulgentGenetics]

Fulgent Genetics is excited to attend the upcoming #ADPD2026 Conference in Copenhagen! If you’re attending AD/PD, we’d love to meet and explore how Fulgent can support your clinical practice, research programs, or global trial needs.

[Fulgent Genetics @FulgentGenetics]

Tomorrow at #ACMG26, catch Beyond DNA: How RNA Changes the Game in Genomic Medicine with Jamie Zdrodowski, MS, CGC, and Katherine Roth, MD at the Exhibition Theater, 10:45 – 11:15 am.
Then stop by Booth #2010 for our complimentary wine bar, poster abstracts, and new product info.

[Fulgent Genetics @FulgentGenetics]

#ACMG26 will be a big event! Our genetic counselors will present three poster abstracts.

Don’t miss the live talk on RNA’s impact on genomic medicine at the Exhibition Theater (Thurs, Mar 12, 10:45 AM ET).

Then stop by Booth #2010 for a complimentary wine bar!

[Fulgent Genetics @FulgentGenetics]

We’re excited to connect at ACMG! Visit our three poster abstracts.

Jay Shaw presents a RISE case report showing how RNA-seq detects aberrant splicing, refines variant classification, and improves molecular diagnoses.

Poster #P043.
Mar 12, 10:30–11:30 AM ET.

[Fulgent Genetics @FulgentGenetics]

We’re excited to connect at ACMG! Visit our three poster abstracts.

Jay Shaw presents a RISE case report showing how RNA-seq detects aberrant splicing, refines variant classification, and improves molecular diagnoses.

Poster #P043.
Mar 12, 10:30–11:30 AM ET.

[Fulgent Genetics @FulgentGenetics]

Catch Jamie Zdrodowski’s poster #P780 at ACMG! Learn about the detection of a COL11A1 variant on prenatal cfDNA screening. Join us on Mar 13, 10:30am – 11:30am ET for insights and Q&A.

Follow for more #ACMG26 updates!

[Fulgent Genetics @FulgentGenetics]

We’re excited to present three poster abstracts at ACMG.

Mitchell Dillon analyzed 240 probands using parallel RNAseq + DNA sequencing to improve variant prioritization, reduce VUS, and boost diagnostic yield.

Poster #P608
Mar 13, 10:30–11:30 AM

Follow us for more updates.

[Fulgent Genetics @FulgentGenetics]

We’re excited to present three poster abstracts at ACMG.

Mitchell Dillon analyzed 240 probands using parallel RNAseq + DNA sequencing to improve variant prioritization, reduce VUS, and boost diagnostic yield.

Poster #P608, Mar 13, 10:30–11:30 AM

Follow us for more updates.